Prilocaine-Induced Methemoglobinemia Following Pacemaker and ICD Implantation: A Retrospective Analysis of Incidence and Clinical Characteristics
Pakistan Heart Journal · 28.02.2026 · 59 (1) · 112-117
DOI: 10.47144/phj.v59i1.3090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Heart Journal, online erschienen am 28.02.2026. Verfasst von Havva Kocayiğit und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
This study presents our experience with prilocaine-induced methemoglobinemia in patients undergoing permanent pacemaker (PPM) or implantable cardioverter defibrillator (ICD) implantation. Methodology: We conducted a retrospective analysis of patients who developed clinically significant methemoglobinemia following PPM or ICD implantation between 2019 and 2023.
Results
Out of 651 patients who underwent PPM or ICD implantation, 19 patients developed methemoglobinemia after prilocaine administration and were included in the analysis. Of these, 68.4% (13 patients) were female, with a mean age of 75.1 ± 10.1 years, indicating a predominantly elderly population. Regarding comorbidities, 16 patients had hypertension, 10 had diabetes mellitus, 7 had coronary artery disease, and 5 had congestive heart failure. A dual-chamber pacemaker was implanted in 12 patients, a single-chamber pacemaker in 3, a dual-chamber ICD in 2, and a single-chamber ICD in 2. The mean haemoglobin level was 11.5 ± 1.3 g/dL, with 13 patients (68.4%) presenting with anaemia. Mean serum albumin was 32.8 ± 3.7 g/dL, with hypoalbuminemia observed in 9 patients (47.4%). The mean glomerular filtration rate was 67.0 ± 23.3 mL/min/1.73 m², and 15 patients (78.9%) had reduced renal function. The average oxygen saturation among those who developed methemoglobinemia was 87.1 ± 2.0%. The mean MetHb level prior to treatment was 10.2 ± 3.9%, which significantly decreased to 1.9 ± 0.5% following treatment (p < 0.001).
Conclusion
Clinicians should consider the possibility of methemoglobinemia in patients with unexplained low oxygen saturation that is inconsistent with their clinical presentation. Prompt administration of methylene blue in patients with comorbidities can lead to rapid clinical improvement.
Zitieren
APA
Kocayiğit, H., Çakmak, B. S., Çakmak, A. C., & Kocayiğit, İ. (2026). Prilocaine-Induced Methemoglobinemia Following Pacemaker and ICD Implantation: A Retrospective Analysis of Incidence and Clinical Characteristics. Pakistan Heart Journal, 59(1), 112-117. https://doi.org/10.47144/phj.v59i1.3090
Vancouver
Kocayiğit H, Çakmak BS, Çakmak AC, Kocayiğit İ. Prilocaine-Induced Methemoglobinemia Following Pacemaker and ICD Implantation: A Retrospective Analysis of Incidence and Clinical Characteristics. Pakistan Heart Journal. 2026;59(1):112-117. doi:10.47144/phj.v59i1.3090
BibTeX
@article{Kocayiit2026,
author = {Kocayiğit, Havva and Çakmak, Betül Sarıbıyık and Çakmak, Ahmet Can and Kocayiğit, İbrahim},
title = {Prilocaine-Induced Methemoglobinemia Following Pacemaker and ICD Implantation: A Retrospective Analysis of Incidence and Clinical Characteristics},
journal = {Pakistan Heart Journal},
year = {2026},
volume = {59},
number = {1},
pages = {112--117},
doi = {10.47144/phj.v59i1.3090}
}
EUVIMED